Jove
Visualize
Contact Us

Related Experiment Videos

Hypercoagulable states. Their causes and management.

K J Bowen1, S J Vukelja

  • 1Department of Medicine, Brooke Army Medical Center, Fort Sam Houston, TX 78234-6200.

Postgraduate Medicine
|February 15, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Paying research participants: a study of current practices in Australia.

Journal of medical ethics·2005
Same author

Behavioral components of high-fat diet hyperphagia: meal size and postprandial satiety.

American journal of physiology. Regulatory, integrative and comparative physiology·2000
Same author

High-dose cyclophosphamide, etoposide and carboplatin with autologous bone marrow support for metastatic breast cancer: long-term results.

Bone marrow transplantation·1998
Same author

Learned suppression of intake based on anticipated calories: cross-nutrient comparisons.

Physiology & behavior·1998
Same author

Gilbert's syndrome co-existing with and masking hereditary spherocytosis.

Annals of hematology·1997
Same author

Weight gain of rats consuming full-fat versus reduced-fat foods.

Annals of the New York Academy of Sciences·1997
Same journal

CV risk: if you aren't testing ACR, you aren't seeing the full picture.

Postgraduate medicine·2026
Same journal

Anti-TNF-induced vasculitis: analysis of data from the French national pharmacovigilance database.

Postgraduate medicine·2026
Same journal

Relationship of serum nesfatin-1 levels with body mass index and c-reactive protein in patients presenting to the emergency department with epileptic seizures.

Postgraduate medicine·2026
Same journal

Clinical pharmacokinetics of colistimethate sodium and formed colistin in patients with renal impairment or on dialysis modalities: a systematic review and implications for precision dosing.

Postgraduate medicine·2026
Same journal

The role of type D personality in pregnancy symptom severity, functional limitations, and maternal ambivalence.

Postgraduate medicine·2026
Same journal

Operational and demographic predictors of leaving without being seen in a high-volume tertiary emergency department: a five-year case-control study.

Postgraduate medicine·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Identifying patients with hypercoagulable states is crucial for preventing thrombosis. Early recognition through medical history and risk factors can reduce severe outcomes, with hereditary thrombosis requiring lifelong anticoagulation.

Area of Science:

  • Internal Medicine
  • Hematology
  • Genetics

Background:

  • Hypercoagulable states, both hereditary and acquired, increase the risk of thrombosis.
  • Prompt identification and management are essential to prevent significant morbidity and mortality.

Purpose of the Study:

  • To highlight the importance of recognizing patients who require evaluation for hypercoagulable states.
  • To emphasize the role of comprehensive patient assessment in identifying at-risk individuals.

Main Methods:

  • Review of medical history, including current medications.
  • Assessment of family history for thrombotic events.
  • Evaluation of circumstantial risk factors contributing to thrombosis.

Main Results:

Related Experiment Videos

  • Thorough patient evaluation can identify individuals susceptible to thrombotic events.
  • Timely intervention based on risk assessment can mitigate adverse outcomes.

Conclusions:

  • Recognition of hereditary or acquired hypercoagulable states is vital for initiating appropriate treatment.
  • Lifelong anticoagulation is recommended for patients diagnosed with hereditary thrombosis to prevent recurrent events.